Cardlytics (CDLX) Stock Statistics & Valuation Metrics

Cardlytics has a market cap or net worth of $64.87M. The enterprise value is $242.34M.

Cardlytics has 54,056,550 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cardlytics’s return on equity (ROE) is -2.70 and return on invested capital (ROIC) is -67.03%.

The current PE Ratio of Cardlytics is ―. Cardlytics’s PEG ratio is -0.16.

In the last 12 months, Cardlytics had revenue of 278.30M and earned -189.30M in profits. Earnings per share was -3.91.

In the last 12 months, operating cash flow was -741.00K and capital expenditures -8.90M, giving a free cash flow of -9.64M billion.

Cardlytics pays an annual dividend of ―, resulting in a dividend yield of ―

Cardlytics upcoming earnings date is Mar 3, 2026, After Close (Confirmed).

Cardlytics as a current ratio of 1.19, with Debt / Equity ratio of -4707.33%

In the past 12 months, Cardlytics has paid 0.00 in taxes.

Cardlytics EV to EBITDA ratio is -2.20, with an EV/FCF ratio of -11.93.

Cardlytics has $43.96M in cash and marketable securities with $221.43M in debt, giving a net cash position of -$177.47M billion.

Gross margin is 44.37%, with operating margin of -70.25%, and net profit margin of -68.02%.

The average price target for Cardlytics is $1.63, which is 11.43% higher than the current price. The consensus rating is Hold